News Conference News ESC 2025 Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF Michael O'Riordan August 29, 2025
News Conference News ESC 2023 DANPACE II: Reducing Atrial Pacing Doesn’t Prevent AF in Sinus Node Disease Todd Neale August 30, 2023
News Opinion Editor's Corner ESC 2023 What’s Going to Be Hot at ESC 2023? Shelley Wood August 15, 2023
News Conference News ESC 2022 INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF Michael O'Riordan August 28, 2022
News Conference News ESC 2021 In HFrEF, AI Shows Promise For Predicting Beta Blocker Response Yael L. Maxwell September 03, 2021
News Conference News ESC 2021 His-bundle Pacing, TAVI Advice Debut in ESC’s Update to Pacing, CRT Guidelines Todd Neale September 01, 2021
News Conference News ESC 2021 New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT Shelley Wood August 28, 2021
News Conference News ESC 2021 SMART-MI: Implant IDs Large Burden of Arrhythmic Events Post-MI Michael O'Riordan August 27, 2021
News Conference News ESC 2020 First-line Ablation With Cryoballoon Gains Support From STOP AF First Todd Neale September 02, 2020
News Conference News ESC 2020 Rhythm Control Cuts First CV Events in Early Atrial Fibrillation: EAST-AFNET 4 Shelley Wood August 29, 2020
News Conference News ESC 2019 Beta-blockers Safe, Effective for HFrEF Patients With Renal Dysfunction: Meta-analysis Yael L. Maxwell September 12, 2019
News Conference News ESC 2018 Cardiac CTA Radiation Dose Has Dropped by Nearly 80% Over the Last Decade L.A. McKeown September 06, 2018
News Conference News ESC 2018 COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure Todd Neale August 27, 2018
News Conference News ESC 2015 Danish Registry Study Shows Potential of Stroke Risk Score in Heart Failure Patients L.A. McKeown August 31, 2015
News Conference News ESC 2012 ESC Congress 2012 Offers Slate of Guidelines, New MI Definition Caitlin E. Cox August 26, 2012